Yet more evidence that MAFLD is more than a name change

doi:10.1016/j.jhep.2020.12.025

Comment

. 2021 Apr;74(4):977-979.

doi: 10.1016/j.jhep.2020.12.025. Epub 2021 Jan 13.

Yet more evidence that MAFLD is more than a name change

Mohammed Eslam¹, Vlad Ratziu², Jacob George³

Affiliations

¹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: mohammed.eslam@sydney.edu.au.
² Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
³ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: jacob.george@sydney.edu.au.

PMID: 33453331
DOI: 10.1016/j.jhep.2020.12.025

Comment

Yet more evidence that MAFLD is more than a name change

Mohammed Eslam et al. J Hepatol. 2021 Apr.

. 2021 Apr;74(4):977-979.

doi: 10.1016/j.jhep.2020.12.025. Epub 2021 Jan 13.

Authors

Mohammed Eslam¹, Vlad Ratziu², Jacob George³

Affiliations

¹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: mohammed.eslam@sydney.edu.au.
² Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.
³ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, NSW, Australia. Electronic address: jacob.george@sydney.edu.au.

PMID: 33453331
DOI: 10.1016/j.jhep.2020.12.025

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.
Eslam M, Sanyal AJ, George J; International Consensus Panel. Eslam M, et al. Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8. Gastroenterology. 2020. PMID: 32044314 Review.
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, Grønbæk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J. Eslam M, et al. J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278004 Review.
Non-alcoholic fatty liver disease: Not time for an obituary just yet!
Singh SP, Anirvan P, Reddy KR, Conjeevaram HS, Marchesini G, Rinella ME, Madan K, Petroni ML, Al-Mahtab M, Caldwell SH, Aithal GP, Hamid SS, Farrell GC, Satapathy SK, Duseja A, Acharya SK, Dassanayake AS, Goh KL. Singh SP, et al. J Hepatol. 2021 Apr;74(4):972-974. doi: 10.1016/j.jhep.2020.10.015. Epub 2020 Dec 16. J Hepatol. 2021. PMID: 33340575 No abstract available.
Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profiling.
Xia M, Zeng H, Wang S, Tang H, Gao X. Xia M, et al. J Hepatol. 2021 Apr;74(4):974-977. doi: 10.1016/j.jhep.2020.10.019. Epub 2020 Dec 16. J Hepatol. 2021. PMID: 33340578 No abstract available.

Cited by

Sex-Specific Contribution of Cardiometabolic Index in Predicting Metabolic Dysfunction-Associated Fatty Liver Disease: Insights from a General Population.
Gu D, Lu Y, Xu B, Tang X. Gu D, et al. Diabetes Metab Syndr Obes. 2023 Nov 30;16:3871-3883. doi: 10.2147/DMSO.S437413. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 38054037 Free PMC article.
Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort.
Zeng J, Jin Q, Yang J, Yang RX, Zhang RN, Zhao J, Fan JG. Zeng J, et al. Hepatol Int. 2023 Dec;17(6):1416-1428. doi: 10.1007/s12072-023-10574-1. Epub 2023 Sep 20. Hepatol Int. 2023. PMID: 37728728
Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate.
Fouad Y. Fouad Y. World J Hepatol. 2023 Feb 27;15(2):123-128. doi: 10.4254/wjh.v15.i2.123. World J Hepatol. 2023. PMID: 36926229 Free PMC article.
NAFLD vs MAFLD: South Asian NAFLD Patients don't Favor Name Change.
Singh SP, Anirvan P, Butt AS, Shrestha A, Dassanayake AS, Shaikh BA, Mahtab MA. Singh SP, et al. Euroasian J Hepatogastroenterol. 2022 Jul;12(Suppl 1):S1-S4. doi: 10.5005/jp-journals-10018-1363. Euroasian J Hepatogastroenterol. 2022. PMID: 36466103 Free PMC article.
Ultrasonographically detected hepatosteatosis independently predicts the presence and severity of coronary artery disease.
Yılmaz A, Yılmaz F, Beydilli İ, Sönmez BM, Duyan M, Özdemir M, Komut S, Aksoy Y. Yılmaz A, et al. Afr Health Sci. 2022 Jun;22(2):273-285. doi: 10.4314/ahs.v22i2.31. Afr Health Sci. 2022. PMID: 36407381 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Yet more evidence that MAFLD is more than a name change

Affiliations

Yet more evidence that MAFLD is more than a name change

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical